 Using targeted electrical signals to harness the bodys natural mechanisms to diagnose and treat a range of diseases Has commercialized its first product, a biomedical signal processing platform called PURE EP To date more than 680 patient cases have been conducted with the PURE EP System across eight clinical sites. What BioSig Technologies does: BioSig Technologies Inc NASDAQ:BSGM is working to develop and deliver advanced signal processing solutions that will unlock the future of bioelectronic medicine. 